Reference
Walendy V, et al. Alemtuzumab induced anti-glomerular basement syndrome in a patient with relapsing-remitting multiple sclerosis. Neurology and Clinical Neuroscience 8: 346-347, No. 5, Sep 2020. Available from: URL: http://doi.org/10.1111/ncn3.12401
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1829, 24 (2020). https://doi.org/10.1007/s40278-020-85614-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-85614-6